Gezen-Ak et al. (2007) carried out a clinical trial including 104 AD patients and 109 age-matched controls, who were genotyped to detect differences in restriction and no restriction sites in intron 8 and exon 9 of the ligand-binding site of the VDR gene. The gene discussed is VDR; the disease is Alzheimer disease.